West Pharmaceutical Services Debt to Equity Ratio 2010-2025 | WST
Current and historical debt to equity ratio values for West Pharmaceutical Services (WST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. West Pharmaceutical Services debt/equity for the three months ending March 31, 2025 was 0.08.
| West Pharmaceutical Services Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$0.94B |
$2.68B |
0.35 |
| 2024-12-31 |
$0.96B |
$2.68B |
0.36 |
| 2024-09-30 |
$0.92B |
$2.75B |
0.34 |
| 2024-06-30 |
$0.91B |
$2.58B |
0.35 |
| 2024-03-31 |
$0.92B |
$2.68B |
0.34 |
| 2023-12-31 |
$0.95B |
$2.88B |
0.33 |
| 2023-09-30 |
$0.89B |
$2.87B |
0.31 |
| 2023-06-30 |
$0.92B |
$2.75B |
0.34 |
| 2023-03-31 |
$0.95B |
$2.78B |
0.34 |
| 2022-12-31 |
$0.93B |
$2.69B |
0.35 |
| 2022-09-30 |
$0.85B |
$2.47B |
0.34 |
| 2022-06-30 |
$0.94B |
$2.42B |
0.39 |
| 2022-03-31 |
$0.97B |
$2.33B |
0.42 |
| 2021-12-31 |
$0.98B |
$2.34B |
0.42 |
| 2021-09-30 |
$0.94B |
$2.20B |
0.43 |
| 2021-06-30 |
$0.90B |
$2.03B |
0.44 |
| 2021-03-31 |
$0.91B |
$1.83B |
0.50 |
| 2020-12-31 |
$0.94B |
$1.86B |
0.51 |
| 2020-09-30 |
$0.86B |
$1.72B |
0.50 |
| 2020-06-30 |
$0.79B |
$1.61B |
0.49 |
| 2020-03-31 |
$0.76B |
$1.49B |
0.51 |
| 2019-12-31 |
$0.77B |
$1.57B |
0.49 |
| 2019-09-30 |
$0.69B |
$1.49B |
0.46 |
| 2019-06-30 |
$0.68B |
$1.45B |
0.47 |
| 2019-03-31 |
$0.67B |
$1.37B |
0.49 |
| 2018-12-31 |
$0.58B |
$1.40B |
0.42 |
| 2018-09-30 |
$0.59B |
$1.35B |
0.44 |
| 2018-06-30 |
$0.59B |
$1.28B |
0.46 |
| 2018-03-31 |
$0.56B |
$1.31B |
0.43 |
| 2017-12-31 |
$0.58B |
$1.28B |
0.46 |
| 2017-09-30 |
$0.61B |
$1.32B |
0.47 |
| 2017-06-30 |
$0.60B |
$1.24B |
0.48 |
| 2017-03-31 |
$0.57B |
$1.17B |
0.48 |
| 2016-12-31 |
$0.60B |
$1.12B |
0.54 |
| 2016-09-30 |
$0.59B |
$1.14B |
0.52 |
| 2016-06-30 |
$0.60B |
$1.11B |
0.54 |
| 2016-03-31 |
$0.59B |
$1.07B |
0.55 |
| 2015-12-31 |
$0.67B |
$1.02B |
0.66 |
| 2015-09-30 |
$0.67B |
$1.00B |
0.67 |
| 2015-06-30 |
$0.67B |
$0.99B |
0.68 |
| 2015-03-31 |
$0.66B |
$0.94B |
0.70 |
| 2014-12-31 |
$0.71B |
$0.96B |
0.75 |
| 2014-09-30 |
$0.70B |
$0.97B |
0.73 |
| 2014-06-30 |
$0.73B |
$0.97B |
0.75 |
| 2014-03-31 |
$0.77B |
$0.94B |
0.83 |
| 2013-12-31 |
$0.77B |
$0.91B |
0.84 |
| 2013-09-30 |
$0.83B |
$0.84B |
0.99 |
| 2013-06-30 |
$0.83B |
$0.78B |
1.06 |
| 2013-03-31 |
$0.83B |
$0.75B |
1.11 |
| 2012-12-31 |
$0.84B |
$0.73B |
1.15 |
| 2012-09-30 |
$0.81B |
$0.72B |
1.13 |
| 2012-06-30 |
$0.78B |
$0.68B |
1.15 |
| 2012-03-31 |
$0.76B |
$0.70B |
1.10 |
| 2011-12-31 |
$0.74B |
$0.66B |
1.14 |
| 2011-09-30 |
$0.71B |
$0.69B |
1.02 |
| 2011-06-30 |
$0.72B |
$0.70B |
1.03 |
| 2011-03-31 |
$0.70B |
$0.66B |
1.06 |
| 2010-12-31 |
$0.67B |
$0.63B |
1.07 |
| 2010-09-30 |
$0.67B |
$0.63B |
1.06 |
| 2010-06-30 |
$0.65B |
$0.57B |
1.14 |
| 2010-03-31 |
$0.67B |
$0.58B |
1.16 |
| 2009-12-31 |
$0.69B |
$0.58B |
1.20 |
| 2009-09-30 |
$0.70B |
$0.57B |
1.23 |
| 2009-06-30 |
$0.69B |
$0.53B |
1.28 |
| 2009-03-31 |
$0.65B |
$0.49B |
1.34 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.094B |
$2.893B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
